0001950047-23-005706.txt : 20231205 0001950047-23-005706.hdr.sgml : 20231205 20231205184258 ACCESSION NUMBER: 0001950047-23-005706 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231205 DATE AS OF CHANGE: 20231205 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Cerevel Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001805387 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39311 FILM NUMBER: 231468017 BUSINESS ADDRESS: STREET 1: 222 JACOBS STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 844-304-2048 MAIL ADDRESS: STREET 1: 222 JACOBS STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02141 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp II DATE OF NAME CHANGE: 20200303 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Akamine Scott CENTRAL INDEX KEY: 0001816720 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O AEON BIOPHARMA, INC. STREET 2: 4040 MACARTHUR BLVD., SUITE 260 CITY: NEWPORT BEACH STATE: CA ZIP: 92660 144 1 primary_doc.xml 144 0001816720 XXXXXXXX LIVE 0001805387 CEREVEL THERAPEUTICS HOLDINGS, INC. 001-39311 222 Jacobs Street Suite 200 Cambridge MA 02141 (844) 304-2048 SCOTT AKAMINE Officer Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 38th Floor New York NY 10004

7500 262500.00 180278078 12/05/2023 NASDAQ Common 12/05/2023 Stock Option Exercise Issuer N 7500 12/05/2023 Cash Y 12/05/2023 08/04/2023 /s/ Scott Akamine